These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17600707)

  • 41. 11beta-Hydroxysteroid dehydrogenase type 1 inhibitors with oleanan and ursan scaffolds.
    Blum A; Favia AD; Maser E
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):132-6. PubMed ID: 18822345
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis and optimization of novel 4,4-disubstituted cyclohexylbenzamide derivatives as potent 11β-HSD1 inhibitors.
    Sun D; Wang Z; Caille S; DeGraffenreid M; Gonzalez-Lopez de Turiso F; Hungate R; Jaen JC; Jiang B; Julian LD; Kelly R; McMinn DL; Kaizerman J; Rew Y; Sudom A; Tu H; Ursu S; Walker N; Willcockson M; Yan X; Ye Q; Powers JP
    Bioorg Med Chem Lett; 2011 Jan; 21(1):405-10. PubMed ID: 21093258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 11beta-hydroxysteroid dehydrogenase type 1 inhibitors: a review of recent patents.
    Boyle CD; Kowalski TJ
    Expert Opin Ther Pat; 2009 Jun; 19(6):801-25. PubMed ID: 19456274
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Discovery and optimization of benzenesulfonanilide derivatives as a novel class of 11β-HSD1 inhibitors.
    Rew Y; DeGraffenreid M; He X; Jaen JC; McMinn DL; Sun D; Tu H; Ursu S; Powers JP
    Bioorg Med Chem Lett; 2012 Jun; 22(11):3786-90. PubMed ID: 22542009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Discovery of novel sulfonamides as potent and selective inhibitors against human and mouse 11β-hydroxysteroid dehydrogenase type 1.
    Xia G; Liu L; Xue M; Liu H; Yu J; Li P; Chen Q; Xiong B; Liu X; Shen J
    Mol Cell Endocrinol; 2012 Jul; 358(1):46-52. PubMed ID: 22410288
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Generation of 3,8-substituted 1,2,4-triazolopyridines as potent inhibitors of human 11β-hydroxysteroid dehydrogenase type 1 (11β-HSD-1).
    Wang H; Robl JA; Hamann LG; Simpkins L; Golla R; Li YX; Seethala R; Zvyaga T; Gordon DA; Li JJ
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4146-9. PubMed ID: 21689935
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cell-based assay for screening 11beta-hydroxysteroid dehydrogenase 1 inhibitors.
    Cho YS; Kim CH; Cheon HG
    Anal Biochem; 2009 Sep; 392(2):110-6. PubMed ID: 19497289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel non-steroidal inhibitors of human 11beta-hydroxysteroid dehydrogenase type 1.
    Vicker N; Su X; Ganeshapillai D; Smith A; Purohit A; Reed MJ; Potter BV
    J Steroid Biochem Mol Biol; 2007 May; 104(3-5):123-9. PubMed ID: 17482805
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening.
    Schuster D; Maurer EM; Laggner C; Nashev LG; Wilckens T; Langer T; Odermatt A
    J Med Chem; 2006 Jun; 49(12):3454-66. PubMed ID: 16759088
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Adamantane sulfone and sulfonamide 11-beta-HSD1 Inhibitors.
    Sorensen B; Winn M; Rohde J; Shuai Q; Wang J; Fung S; Monzon K; Chiou W; Stolarik D; Imade H; Pan L; Deng X; Chovan L; Longenecker K; Judge R; Qin W; Brune M; Camp H; Frevert EU; Jacobson P; Link JT
    Bioorg Med Chem Lett; 2007 Jan; 17(2):527-32. PubMed ID: 17070044
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 11beta-Hydroxysteroid dehydrogenase 1 inhibiting constituents from Eriobotrya japonica revealed by bioactivity-guided isolation and computational approaches.
    Rollinger JM; Kratschmar DV; Schuster D; Pfisterer PH; Gumy C; Aubry EM; Brandstötter S; Stuppner H; Wolber G; Odermatt A
    Bioorg Med Chem; 2010 Feb; 18(4):1507-15. PubMed ID: 20100662
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and evaluation of piperidine urea derivatives as efficacious 11β-hydroxysteroid dehydrogenase type 1 inhibitors in diabetic ob/ob mice.
    Zhang L; Chen J; Ning M; Zou Q; Leng Y; Shen J
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2748-52. PubMed ID: 22440625
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1.
    Balázs Z; Nashev LG; Chandsawangbhuwana C; Baker ME; Odermatt A
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):117-22. PubMed ID: 19010388
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Structure-based virtual screening for identification of novel 11beta-HSD1 inhibitors.
    Yang H; Shen Y; Chen J; Jiang Q; Leng Y; Shen J
    Eur J Med Chem; 2009 Mar; 44(3):1167-71. PubMed ID: 18653260
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Substituted phenyl triazoles as selective inhibitors of 11β-Hydroxysteroid Dehydrogenase Type 1.
    Sun W; Maletic M; Mundt SS; Shah K; Zokian H; Lyons K; Waddell ST; Balkovec J
    Bioorg Med Chem Lett; 2011 Apr; 21(7):2141-5. PubMed ID: 21334894
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Discovery of 3-hydroxy-4-cyano-isoquinolines as novel, potent, and selective inhibitors of human 11β-hydroxydehydrogenase 1 (11β-HSD1).
    Wu SC; Yoon D; Chin J; van Kirk K; Seethala R; Golla R; He B; Harrity T; Kunselman LK; Morgan NN; Ponticiello RP; Taylor JR; Zebo R; Harper TW; Li W; Wang M; Zhang L; Sleczka BG; Nayeem A; Sheriff S; Camac DM; Morin PE; Everlof JG; Li YX; Ferraro CA; Kieltyka K; Shou W; Vath MB; Zvyaga TA; Gordon DA; Robl JA
    Bioorg Med Chem Lett; 2011 Nov; 21(22):6693-8. PubMed ID: 21983444
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mono-carbonyl curcumin analogues as 11β-hydroxysteroid dehydrogenase 1 inhibitors.
    Lin H; Hu GX; Guo J; Ge Y; Liang G; Lian QQ; Chu Y; Yuan X; Huang P; Ge RS
    Bioorg Med Chem Lett; 2013 Aug; 23(15):4362-6. PubMed ID: 23800686
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Discovery of 4-heteroarylbicyclo[2.2.2]octyltriazoles as potent and selective inhibitors of 11beta-HSD1: novel therapeutic agents for the treatment of metabolic syndrome.
    Gu X; Dragovic J; Koo GC; Koprak SL; LeGrand C; Mundt SS; Shah K; Springer MS; Tan EY; Thieringer R; Hermanowski-Vosatka A; Zokian HJ; Balkovec JM; Waddell ST
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5266-9. PubMed ID: 16185866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pyridine amides as potent and selective inhibitors of 11beta-hydroxysteroid dehydrogenase type 1.
    Wang H; Ruan Z; Li JJ; Simpkins LM; Smirk RA; Wu SC; Hutchins RD; Nirschl DS; Van Kirk K; Cooper CB; Sutton JC; Ma Z; Golla R; Seethala R; Salyan ME; Nayeem A; Krystek SR; Sheriff S; Camac DM; Morin PE; Carpenter B; Robl JA; Zahler R; Gordon DA; Hamann LG
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3168-72. PubMed ID: 18485702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis of new glycyrrhetinic acid derived ring A azepanone, 29-urea and 29-hydroxamic acid derivatives as selective 11β-hydroxysteroid dehydrogenase 2 inhibitors.
    Gaware R; Khunt R; Czollner L; Stanetty C; Da Cunha T; Kratschmar DV; Odermatt A; Kosma P; Jordis U; Classen-Houben D
    Bioorg Med Chem; 2011 Mar; 19(6):1866-80. PubMed ID: 21376605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.